Nov 11, 2021 · 35m · we-live-to-build
He Called It a State of Flow Multiplied by 100
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of the 'We Live to Build' podcast, host Sean Weisbrot and serial entrepreneur Mark Benecke explore how structured psychedelic microdosing can overcome burnout, elevate cognitive flow, and transform executive leadership and personal relationships.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Sean holds 41.3% of the talking time here. How this is scored →
speaking balance: gold is Sean, purple is the guest (3 minute bins)
Mark directly challenges Sean's sweeping assertion that everyone should trip at age 26, warning that psychedelics can be intensely terrifying if users are not mentally prepared.
Hardest push from Sean ▶ 31:30 Sean insists microdosing prevents bad tripsSean counters Mark's warning about horrifying bad trips by distinguishing between full doses and sub-perceptual microdoses designed to eliminate hallucinogenic risk.
Biggest teaching moment ▶ 21:49 Mark breaks down stimulant and caffeine interactionsMark explains the practical pharmacological friction of combining stimulants like modafinil or caffeine with LSD, explaining the metallic taste and physical jitters it creates.
Sean holds their own ▶ 32:00 Sean breaks down stealth biotech psilocin extractionSean demonstrates deep industry research by detailing how stealth biotech startups isolate pure psilocin and analogize the sector's regulatory trajectory to CBD versus THC.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Sean as informed peer | Guest teaching | Guest disagreement | Sean pushing back | Why |
|---|---|---|---|---|---|---|
| Mark Benecke's Background and Entrepreneurial Origins | 2 | 1 | 0 | 0 | Sean introduces his personal interest in psychedelic research and invites Mark to share his background. Mark gives a standard biographical overview of his family's shoe factory bankruptcy in El Salvador and taking over the family auto dealership. | |
| First LSD Experience and Exploration of Microdosing | 1 | 3 | 1 | 0 | Mark recounts his initial apprehension, dismantles the common misconception that LSD never leaves the human body, and describes discovering microdosing to overcome creative blocks in writing while Sean listens. | |
| Microdosing Benefits, the Flow State, and Mental Limits | 1 | 2 | 0 | 0 | Mark shares detailed experiential observations about microdosing inducing an intense flow state, heightened empathy, and eventual depressive ideation after 14 months of continuous use. Sean acts purely as an inquisitive listener asking clarifying questions. | |
| Historical Perspectives and Healing Childhood Trauma | 5 | 1 | 1 | 1 | Sean dominates this segment with an extended monologue about his ex-girlfriend's psychological breakthrough on LSD and cites historical military PTSD research. Mark offers a brief sarcastic interjection about gateway drugs. | |
| Substance Interactions, Leadership Transformation, and Family Relationships | 3 | 3 | 0 | 1 | Sean asks specific questions about stacking stimulants and leadership dynamics. Mark educates Sean on how caffeine negatively interacts with LSD to create physical jitters and explains how heightened empathy helped him retain a struggling employee. | |
| Trip Vulnerabilities, Intentionality, and the Future of Psychedelic Biotech | 6 | 3 | 2 | 4 | When Sean proposes that everyone take psychedelics at 26, Mark cautions against blanket recommendations due to terrifying bad trips. Sean firmly clarifies that microdosing avoids hallucinogenic spirals and details biotech innovations extracting non-hallucinogenic psilocin. |